These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2826435)

  • 41. Neurotensin high affinity binding sites and endopeptidase 24.11 are present respectively in the meningothelial and in the fibroblastic components of human meningiomas.
    Mailleux P; Przedborski S; Beaumont A; Verslijpe M; Depierreux M; Levivier M; Kitabgi P; Roques BP; Vanderhaeghen JJ
    Peptides; 1990; 11(6):1245-53. PubMed ID: 1965035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor.
    Herberg JT; Codina J; Rich KA; Rojas FJ; Iyengar R
    J Biol Chem; 1984 Jul; 259(14):9285-94. PubMed ID: 6086631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bovine cerebellum endothelin receptor: solubilization and identification.
    Schvartz I; Ittoop O; Hazum E
    Endocrinology; 1990 Jun; 126(6):3218-22. PubMed ID: 2161752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS.
    Simon J; Benyhe S; Abutidze K; Borsodi A; Szücs M; Tóth G; Wollemann M
    J Neurochem; 1986 Mar; 46(3):695-701. PubMed ID: 3005492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solubilization and characterization of the serotonin 5-HT1c site from pig choroid plexus.
    Yagaloff KA; Hartig PR
    Mol Pharmacol; 1986 Feb; 29(2):120-5. PubMed ID: 3951427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solubilization of pituitary GnRH binding sites by means of a zwitterionic detergent.
    Winiger BP; Birabeau MA; Lang U; Capponi AM; Sizonenko PC; Aubert ML
    Mol Cell Endocrinol; 1983 Jul; 31(1):77-91. PubMed ID: 6309585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solubilization of brain alpha-2 adrenoceptor with a zwitterionic detergent: preservation of agonist binding and its sensitivity to GTP.
    Sladeczek F; Bockaert J; Rouot B
    Biochem Biophys Res Commun; 1984 Mar; 119(3):1116-21. PubMed ID: 6324778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution.
    Kitabgi P; Rostène W; Dussaillant M; Schotte A; Laduron PM; Vincent JP
    Eur J Pharmacol; 1987 Aug; 140(3):285-93. PubMed ID: 2888670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solubilization of high affinity peptide-YY receptors from porcine brain.
    Inui A; Okita M; Miura M; Hirosue Y; Nakajima M; Shii K; Baba S; Balasubramaniam A; Kasuga M
    Endocrinology; 1992 Apr; 130(4):2120-8. PubMed ID: 1312444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
    Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solubilization and characterization of rat brain alpha 2-adrenergic receptor.
    Matsui H; Asakura M; Tsukamoto T; Imafuku J; Ino M; Saitoh N; Miyamura S; Hasegawa K
    J Neurochem; 1985 May; 44(5):1625-32. PubMed ID: 2985758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of neurotensin binding sites in intact and solubilized bovine brain membranes.
    Mills A; Demoliou-Mason CD; Barnard EA
    J Neurochem; 1988 Mar; 50(3):904-11. PubMed ID: 3339364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solubilization of active brain alpha 1-adrenoceptors by a zwitterionic detergent.
    Guicheney P; Rappaport A; Marcel D
    J Neurochem; 1983 Jul; 41(1):56-61. PubMed ID: 6306172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Quirion R; Welner S; Gauthier S; Bédard P
    Synapse; 1987; 1(6):559-66. PubMed ID: 2843996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of neurotensin binding sites on rat mesencephalic cells in primary culture.
    Dana C; Pelaprat D; Vial M; Brouard A; Lhiaubet AM; Rostene W
    Brain Res Dev Brain Res; 1991 Aug; 61(2):259-64. PubMed ID: 1661213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
    Baron B; Gavish M; Sokolovsky M
    Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of solubilized bradykinin B2 receptors from smooth muscle and mucosa of guinea pig ileum.
    Ransom RW; Young GS; Schneck K; Goodman CB
    Biochem Pharmacol; 1992 Apr; 43(8):1823-7. PubMed ID: 1315547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurotensin binds with high affinity to small cell lung cancer cells.
    Allen AE; Carney DN; Moody TW
    Peptides; 1988; 9 Suppl 1():57-61. PubMed ID: 2856809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurotensin receptors. Binding properties, transduction mechanisms, and purification.
    Vincent JP
    Ann N Y Acad Sci; 1992; 668():90-100. PubMed ID: 1334392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.